Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Passive immunotherapy for encephalitis caused by herpes simplex virus.

K S Erlich, J Mills

    Reviews of Infectious Diseases
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro- and Prospective Study Within the GEON.

    Drug testing and analysis·2025
    Same author

    First Measurement of η Meson Production in Neutrino Interactions on Argon with MicroBooNE.

    Physical review letters·2024
    Same author

    First Double-Differential Measurement of Kinematic Imbalance in Neutrino Interactions with the MicroBooNE Detector.

    Physical review letters·2023
    Same author

    First Measurement of Quasielastic Λ Baryon Production in Muon Antineutrino Interactions in the MicroBooNE Detector.

    Physical review letters·2023
    Same author

    The fast camera (Fastcam) imaging diagnostic systems on the DIII-D tokamak.

    The Review of scientific instruments·2023
    Same author

    First Constraints on Light Sterile Neutrino Oscillations from Combined Appearance and Disappearance Searches with the MicroBooNE Detector.

    Physical review letters·2023

    Passive immunotherapy using human immunoglobulin effectively reduced mortality and prolonged survival in a mouse model of herpes simplex virus type 2 encephalitis. The treatment

    Area of Science:

    • Virology
    • Immunology
    • Neurology

    Background:

    • Passive antibody administration is explored for herpes simplex virus (HSV) treatment.
    • Previous studies suggest T lymphocytes may be crucial for antibody efficacy.
    • HSV infections, particularly encephalitis, pose significant health risks.

    Purpose of the Study:

    • To evaluate the efficacy of passive immunotherapy with human immunoglobulin in a mouse model of HSV type 2 encephalitis.
    • To determine the dose-dependency and timing of administration for passive antibody therapy.

    Main Methods:

    • A mouse model of HSV type 2 encephalitis was utilized.
    • Human immunoglobulin (1,250 mg/kg) was administered intraperitoneally before or after intranasal viral challenge.
    • Mortality and survival rates were monitored.

    Related Experiment Videos

    Main Results:

    • Intraperitoneal administration of human immunoglobulin significantly reduced mortality and prolonged survival in HSV-2 infected mice.
    • The therapeutic effect was dose-dependent, with higher antibody titers correlating with better outcomes.
    • Treatment was effective when given up to 8 hours post-infection.

    Conclusions:

    • Passive immunotherapy with human immunoglobulin is a promising therapeutic strategy for severe HSV infections.
    • The findings support the potential for clinical trials of passive immunotherapy in patients with HSV encephalitis.
    • Further research into the mechanisms of antibody efficacy in HSV infections is warranted.